These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12133581)

  • 21. Kainic acid lesion-induced nigral neuronal death.
    Foster JA; Bezin L; Groc L; Christopherson PL; Levine RA
    J Chem Neuroanat; 2003 Aug; 26(1):65-73. PubMed ID: 12954531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
    Liang ZQ; Li YL; Zhao XL; Han R; Wang XX; Wang Y; Chase TN; Bennett MC; Qin ZH
    Brain Res; 2007 May; 1145():190-203. PubMed ID: 17368433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
    Bentea E; Sconce MD; Churchill MJ; Van Liefferinge J; Sato H; Meshul CK; Massie A
    Neurosci Lett; 2015 Apr; 593():1-6. PubMed ID: 25766755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.
    Pierre SR; Lemmens MA; Figueiredo-Pereira ME
    J Neuroinflammation; 2009 Jul; 6():18. PubMed ID: 19630993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
    Zhang W; Zhang L; Liu L; Wang X
    Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
    Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
    Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
    Cintra A; Aguirre JA; Andbjer B; Finnman UB; Hagman M; Agnati LF; Höglund C; Möller A; Fuxe K
    Neurosci Lett; 1999 Oct; 274(1):5-8. PubMed ID: 10530506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
    Lessard A; Pickel VM
    Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.
    Janson AM; Fuxe K; Agnati LF; Kitayama I; Härfstrand A; Andersson K; Goldstein M
    Brain Res; 1988 Jul; 455(2):332-45. PubMed ID: 2900058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages-mediated neurotoxic effects of intra-nigral manganese administration are attenuated by minocycline.
    Ponzoni S
    Neurosci Lett; 2012 Jan; 506(1):136-40. PubMed ID: 22085690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible intermixing of neurons from the subthalamic nucleus and substantia nigra pars compacta in the guinea-pig.
    Overton PG; O'Callaghan JF; Greenfield SA
    Exp Brain Res; 1995; 107(2):151-65. PubMed ID: 8773236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.
    Martí MJ; Saura J; Burke RE; Jackson-Lewis V; Jiménez A; Bonastre M; Tolosa E
    Brain Res; 2002 Dec; 958(1):185-91. PubMed ID: 12468044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.
    Haobam R; Tripathy D; Kaidery NA; Mohanakumar KP
    Rejuvenation Res; 2015 Apr; 18(2):173-84. PubMed ID: 25546608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral effects of intra-nigral microinjections of manganese chloride: interaction with nitric oxide.
    Ponzoni S; Guimarães FS; Del Bel EA; Garcia-Cairasco N
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):307-25. PubMed ID: 10800753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor.
    Díaz-Véliz G; Mora S; Gómez P; Dossi MT; Montiel J; Arriagada C; Aboitiz F; Segura-Aguilar J
    Pharmacol Biochem Behav; 2004 Feb; 77(2):245-51. PubMed ID: 14751451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.